AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,770 | -19.7% | 1,000,000 | 0.0% | 0.33% | +11.0% |
Q2 2023 | $9,680 | -11.7% | 1,000,000 | 0.0% | 0.30% | -53.9% |
Q1 2023 | $10,960 | +153.7% | 1,000,000 | 0.0% | 0.65% | +170.1% |
Q4 2022 | $4,320 | -99.9% | 1,000,000 | 0.0% | 0.24% | -24.9% |
Q3 2022 | $7,520,000 | -25.2% | 1,000,000 | 0.0% | 0.32% | -40.2% |
Q2 2022 | $10,050,000 | -18.8% | 1,000,000 | 0.0% | 0.54% | +3.7% |
Q1 2022 | $12,380,000 | -45.9% | 1,000,000 | 0.0% | 0.52% | -16.6% |
Q4 2021 | $22,870,000 | +3.3% | 1,000,000 | 0.0% | 0.62% | +25.5% |
Q3 2021 | $22,130,000 | +70.8% | 1,000,000 | 0.0% | 0.50% | +88.2% |
Q2 2021 | $12,960,000 | -0.2% | 1,000,000 | 0.0% | 0.26% | +14.8% |
Q1 2021 | $12,985,000 | -6.1% | 1,000,000 | 0.0% | 0.23% | -22.9% |
Q4 2020 | $13,830,000 | -6.1% | 1,000,000 | 0.0% | 0.30% | -17.0% |
Q3 2020 | $14,730,000 | +0.7% | 1,000,000 | +11.1% | 0.36% | -12.5% |
Q2 2020 | $14,625,000 | +34.4% | 900,000 | +20.0% | 0.41% | -11.1% |
Q1 2020 | $10,883,000 | – | 750,000 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |